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Abstract
Background—Tobacco use is a major risk factor for cardiovascular disease (CVD) and is the 
leading preventable cause of death, disease, and disability in the United States. The CDC’s Well-
Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program 
addresses the heart health of low-income under- or uninsured women between the ages of 40 and 
64 years. This article discusses WISEWOMAN’s key approaches to smoking cessation and their 
impact on WISEWOMAN participants’ cardiovascular health.
Methods—A longitudinal retrospective analysis was conducted using data from 21 funded CDC 
programs from July 2008 to June 2013. Data were collected on 149,767 women to assess CVD 
risk, smoking status, and utilization of programs related to tobacco cessation.
Results—The overall prevalence of smoking among the WISEWOMAN population during this 
period was 28%. Increases in referrals to tobacco quitlines, tobacco-cessation counseling, lifestyle 
interventions, and other community-based tobacco-cessation programs contributed to a 15% 
smoking-cessation rate among smokers who returned for a rescreening assessment over the 5-year 
program period.
Conclusion—The WISEWOMAN program has observed a smoking-cessation rate of 15% over 
the 5-year program period. WISEWOMAN’s key approaches include continuous technical 
assistance that highlights quitline referrals, motivational interviewing done by program staff, and 
professional-development strategies for WISEWOMAN healthcare providers. WISEWOMAN will 
continue its programmatic emphasis on smoking cessation by partnering with state tobacco-
cessation programs to work toward a lower smoking-prevalence rate among program participants.
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In the United States, women’s health is affected by their cardiovascular disease (CVD) 
status. Women are at as great a risk from heart disease and stroke as men are.1–2 However, 
women perceive their risk to be lower than that of men.3–4
The CDC’s Well-Integrated Screening and Evaluation for Women Across the Nation 
(WISEWOMAN) program addresses the heart health of women who are under- or uninsured 
and low income, with a priority population between the ages of 40 and 64 years.5 Eligible 
women must be enrolled in the National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP), which is administered by CDC and provides cancer-screening 
services. The WISEWOMAN program funded 19 state health departments and 2 Alaska 
Native organizations between 2008 and 2013. The WISEWOMAN programs provide 
cardiovascular health screenings, lifestyle interventions (LSIs), and community-based 
resources to enrolled women. The program focuses on the reduction and prevention of five 
major risk factors for heart disease: hypertension (high blood pressure), diabetes, high 
cholesterol, overweight/obesity, and smoking. Women enrolled in WISEWOMAN have 
greater health disparities resulting from minority racial and ethnic group membership, low 
socioeconomic status, and limited access to healthcare services.6–11
Between July 1, 2008, and June 30, 2013, WISEWOMAN provided 217,415 CVD 
screenings to 149,767 low-income women, 44% of whom were members of racial and ethnic 
minorities. Approximately 90% of WISEWOMAN participants have at least one of the five 
major risk factors for CVD.5
Cigarette smoking and exposure to secondhand smoke are major risk factors for CVD.12–13 
Cigarette smoking causes more than 151,000 deaths from cardiovascular diseases each 
year.13 The national prevalence of smoking among women is 15.8%.14 The overall smoking 
prevalence among WISEWOMAN participants is 28%, which is much higher than the 
national average.
Proven strategies to help people quit smoking include advice to quit from healthcare 
providers; individual, group, and telephone counseling; and seven FDA-approved cessation 
medications.15 Over the past 10 years, telephone quitlines providing counseling services to 
smokers who wish to quit have been established in all 50 states, the District of Columbia, 
Puerto Rico, and Guam.16 Quitlines increase quit rates, have broad reach, and are effective 
with diverse populations.15 Quitlines provide callers with a range of services, including 
counseling, practical information on how to quit, referral to other cessation resources, 
mailed self-help materials, and, in many cases, free or discounted cessation medication.17 
Most state quitlines have implemented a fax-referral system.18 In this model, after advising a 
smoker to quit and assessing the smoker’s readiness to quit, the healthcare provider faxes a 
referral form to the quitline if the smoker is interested in quitting and agrees to be referred. 
Counselors at the quitline will then contact the smoker to begin cessation services. Such fax-
referral systems have proved effective in providing services to smokers who want to quit.19 
In addition, some state quitlines, are beginning to explore e-referrals, in which a provider 
refers a patient to the quitline electronically from the patient’s electronic health records,19–20 
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along with the CDC’s compilations of current best practices for comprehensive tobacco 
control programs.21
A complementary evidence-based strategy is for tobacco-control programs to work with 
healthcare providers to increase the advice to smokers to quit.15 The 5-As framework (ask, 
advise, assess, assist and arrange) gives healthcare providers an opportunity to affect the 
outcome at each clinical encounter—whether through assessing a smoker’s willingness to 
make a quit attempt, encouraging a quit attempt, offering assistance with quitting, assisting 
with problem solving, or, at the very least, providing motivation to quit.15
WISEWOMAN program activities
Between 2008 and 2013, the WISEWOMAN program’s emphasis on reducing smoking and 
secondhand exposure increased. Program guidance for smoking cessation stressed quitline 
referrals and feedback to WISEWOMAN programs on the smoking status of women who 
participated. Technical assistance to funded programs on smoking cessation was two-
pronged. First, WISEWOMAN program staff was advised to include tobacco-use cessation 
in motivational interviewing with each woman who smoked. Second, professional 
development was conducted for healthcare providers so that the 5-As framework (ask about 
tobacco use, advise to quit, assess willingness to make a quit attempt, assist in quit attempt, 
and arrange follow-up) was used with all patients at every clinic visit. Assistance in quit 
attempts included linkages to quitlines and referrals to appropriate community cessation 
services. Community referrals to appropriate cessation services are an integral part of the 
program. In addition, LSIs provide cessation counseling as part of the intervention 
curriculum as mentioned in CDC’s WISEWOMAN program guidance and resource 
document.
WISEWOMAN program examples
State program—The Pennsylvania WISEWOMAN (PAWW) program is an example of a 
systematic public health approach to decrease tobacco use among PAWW clients and the 
larger community population. Funded in 2008, PAWW reported a smoking prevalence of 
25% at baseline screening in a small number of clinics in limited geographic areas. At this 
early point in the program, no participants were referred to the state quitline, and only 4% 
were linked to community-based tobacco-cessation resources. In the following 24 to 36 
months, the program expanded its reach to new clinics, service providers, and geographic 
areas in the state. From July 1, 2012, to June 30, 2013, the program documented a smoking 
rate of 34% among participants across the statewide program. To reduce this high prevalence 
rate, the program worked more aggressively with clinicians. A key goal was to increase 
referrals to tobacco-cessation support services in community-based organizations and 
through the state quitline. Clinicians in the healthcare system were identified as those most 
likely to make referrals to cessation services. The program worked with the Pennsylvania 
Department of Health Tobacco Prevention and Control Division (TPC) and the Pennsylvania 
Free Quitline Fax to Quit Program to train clinicians on tobacco-cessation services available 
to all clinic patients, including WISEWOMAN participants. As a result of this partnership, 
provider knowledge of available cessation resources and referral procedures increased. The 
training program was piloted in two clinics before statewide implementation.
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The two pilot clinics were located in western Pennsylvania. At each clinic, every staff person
—from the front-desk clerk to the clinic manager who interacted with clients—participated 
in the training. As a result, all clinic staff had a uniform understanding of the referral process 
and the ability to explain the services offered to a client. The on-line training took 
approximately 45 minutes to 1 hour to complete, covering current guidelines for and 
implementation of smoking-cessation interventions, the complexity of smoking behavior, 
nicotine addiction, brief intervention strategies using the 5-As framework, a summary of 
appropriate cessation pharmacotherapy, and Fax to Quit Program procedures and 
reporting.15 Members of the clinic staff were asked to commit to system changes, such as 
including patient Fax to Quit forms in standard operating procedures and providing ongoing 
training for new employees. Program monitoring and evaluation were important parts of the 
program and included confirmation of Fax to Quit Program referrals through reports and 
followup assessments. Following the pilot, the program recruited 680 professionals 
statewide to receive the on-line Fax to Quit Program training (Table 1). These professionals 
provided healthcare services to women enrolled in NBCCEDP and in the WISEWOMAN 
program. These healthcare providers also served primarily low-income, disadvantaged 
people who were not enrolled in NBCCEDP and WISEWOMAN; the referral procedures 
were implemented for all clinic clients. The program continued to work with TPC to 
promote additional cessation services and training opportunities. By June 2013, 91% of 
PAWW smokers were referred to cessation programs, including the state quitline, through 
the Fax to Quit Program referral process.
Tribal program—The Southeast Alaska Regional Health Consortium (SEARHC) is a 
comprehensive healthcare services organization that serves Alaska Natives and other racial 
and ethnic groups living in southeast Alaska. The SEARHC WISEWOMAN (SEARHC 
WW) program has been funded since 1999, with approximately 68% of participants self-
identifying as non-Hispanic American Indian/Alaskan Native women. Remaining 
participants identify as white, non-Hispanic black, and Asian/Pacific Islanders.
SEARHC Health System changes were implemented at numerous clinics serving 
WISEWOMAN participants. Unlike many state-funded programs, SEARHC noted that, at 
baseline screening, few participants accepted the offer to receive counseling services through 
the proactive Alaska (AK) Quitline. Most tobacco users in the program were Alaska Natives, 
who are most comfortable with in-person services delivery. To address this cultural norm, 
SEARHC had three certified tobacco-cessation counselors who offered counseling services 
throughout the region; two of the counselors were based in the largest communities in 
southeast Alaska. FDA-approved cessation medications were provided by healthcare 
professionals to all SEARHC WW smokers, as appropriate. Forty-six percent of SEARHC 
WW smokers received one-on-one counseling services medication therapy, as appropriate.
Since 2000, the SEARHC WW and the SEARHC Women’s Health (SEARHC WH) 
program have worked closely with community partners and other programs supported by 
SEARHC to implement environmental approaches to reduce tobacco use and eliminate 
exposure to secondhand smoke. These environmental approaches included increased tobacco 
pricing, smoke-free ordinances and regulations, voluntary smoke-free businesses, smoke-
free tribal facilities, and communication campaigns. Community partners and SEARHC 
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worked together, and tobacco taxes were raised in the two largest service areas: Juneau in 
2003 and Sitka in 2005. The tax in Juneau was increased in 2009 from $0.30 a pack to 
$1.22–23 The tax revenue in Sitka was dedicated to funding the community hospital, and a 
portion was used for community-based tobacco-cessation services that are available to all 
tobacco users in the community, including women enrolled in WISEWOMAN.
In partnership with the SEARHC Tobacco and Diabetes programs, SEARHC WW and 
SEARHC WH conducted a social-marketing project targeting women ages 25–64. Begun in 
2008 and continuing for 3 years, the social-marketing campaign used a phased approach. At 
different times during the 3 years, various media strategies and outlets were used. Ads were 
placed on the radio and in print publications. Postcards with tobacco-free messages were 
mailed to women. Monthly “Tips to Quit” flyers were also mailed. Ads were placed in 
theaters before the feature films. Flyers and posters with tobacco-free messages were placed 
in clinics and public areas in the communities. Finally, earned-media strategies were used, 
resulting in additional attention to health issues in print and broadcast media. Earned-media 
stories included profiles of women who quit smoking and the resulting health benefits they 
enjoyed. The 3-year media campaign coincided with the first 3 years of the WISEWOMAN 
funding period. Beginning in 2009, smoke-free housing policies were promoted in Juneau, 
Sitka, and Petersburg.
The synergy of environmental and health systems approaches contributes to changing social 
norms and creating a supportive environment for smokers who quit. SEARHC’s Behavior 
Risk Factor Survey was conducted in the service area; using those data, they found a 
significant decrease in the number of Alaska Native/American Indians smokers from 37% in 
2005 to 24% in 2011. Data from the SEARHC WW program reflected this trend. Of 
participants who received cessation counseling, 25% reported not smoking at a clinic 
rescreening visit at least 12 months later. In contrast, of participants who did not receive 
counseling to quit, 15% reported not smoking at their last rescreening visit.
Materials and Methods
WISEWOMAN program activities ultimately have an impact on the women served. When 
examining aggregate data for all 21 funded WISEWOMAN programs, national trends 
emerge. These data depict a population group that is at risk for cardiovascular disease as a 
result of smoking and exposure to secondhand smoke. The data also show reductions in the 
smoking prevalence among WISEWOMAN participants.
The WISEWOMAN program collected cardiovascular health-screening data from 19 state 
health departments and 2 tribal organizations in Alaska from July 1, 2008, to June 30, 2013. 
This analysis contains longitudinal data gathered on the 149,767 women screened in the 
program. The variables of interest are smoking status (smoker or nonsmoker), race/ethnicity 
(non-Hispanic white, non-Hispanic black, Hispanic, non-Hispanic Asian/Pacific Islander, 
and non-Hispanic American Indian/Alaskan Native), age (younger than 40, 40–49, 50–64, 
65 and older), blood pressure (systolic blood pressure ≥ 140mmHg and/or diastolic blood 
pressure ≥ 90 mmHg), blood cholesterol (total cholesterol ≥ 240 mg/dL), blood glucose ( ≥ 
125 mg/dL) or glycated hemoglobin (A1c) ( ≥ 6.5%), body mass index (BMI) ( ≥ 25), 
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quitline referrals (yes or no), tobacco counseling LSIs (yes or no), and tobacco-cessation 
community-based resources (yes or no). All analyses were performed using SAS Version 9.3 
software (Cary, NC). Odds ratios (OR) using logistic regression models were used to 
determine differences in CVD risk factors between smokers and nonsmokers and what 
attributes increased the likelihood that a woman would quit smoking. All adjusted ORs are 
reported with a 95% confidence interval (CI). For all final analyses, a forward-selection 
approach was adopted that includes the most significant variables ( p < 0.05). To increase the 




The 149,767 participants screened received 217,415 screenings from July 1, 2008, to June 
30, 2013; 44% were racial and ethnic minorities. Education levels varied within the 
program; the majority of participants (68%) had received either a high school (or equivalent) 
or some college (or higher) education. Ninety-six percent of participants were in the priority 
population age range of 40–64 years (Figs. 1–3). The prevalence of CVD risk factors for 
these women is as follows: 40% were hypertensive, 31% had high cholesterol levels, 17% 
were diabetic, and 76% were overweight or obese (Table 2).
The overall prevalence of smoking among the WISEWOMAN population was 28%. When 
stratified by race, non-Hispanic American Indian/Alaskan Natives had the highest 
prevalence of smoking at 42%, with non-Hispanic whites following at 35% and non-
Hispanic blacks at 27%. Hispanics and non-Hispanic Asian and Pacific Islanders had the 
lowest smoking prevalence at 9% and 4%, respectively.
Smoking prevalence among WISEWOMAN participants varied by education status and age 
group, as well as location. Among those with some high school education, 36% were 
smokers, whereas 26% of women with some college education were smokers. When 
participants were stratified by age, the prevalence of smoking decreased as women aged. 
Thirty-two percent of women 40–49 years old were smokers, compared to 24% of women 
50–64 years old. As expected, the prevalence of smoking also varied markedly from 
program to program. West Virginia had the highest prevalence of smokers at 43%; Utah and 
California had the lowest, with 8% and 7%, respectively. Among WISEWOMAN 
participants who smoked, 38% were hypertensive, 30% had high cholesterol levels, 69% 
were overweight or obese, and 14% had diabetes. There was a statistically significant 
difference in BMI among smokers and nonsmokers. Smokers had a decreased likelihood of 
being obese when compared to nonsmokers (OR = 0.59, 95% CI: 0.58–0.61).
Beginning on July 1, 2010, WISEWOMAN added a question about secondhand smoke 
exposure to the screening assessment. Among all participants, 16% were exposed to 
secondhand smoke while at home. However, when they were stratified by smoking status, 
we found that 8% of nonsmokers were exposed to secondhand smoke. WISEWOMAN 
smokers were at additional risk, as 43% of them were also exposed to secondhand smoke 
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while at home. Also of note is that 75% of these smokers were exposed to secondhand 
smoke every day.
Program resources
The WISEWOMAN program included quitline linkages, cessation-counseling referrals, and 
community-based cessation programs. Smoking-cessation interventions included proactive 
telephone quitline referral. Tobacco-cessation counseling was included as part of LSIs, along 
with referral to other community-based tobacco-cessation programs. Proactive quitlines 
provide many services, including individualized tobacco counseling, support for quit 
attempts, help to prevent relapse, educational materials, and, in some cases, nicotine-
replacement therapy or other cessation medications. Counseling, as part of LSIs, includes 
one-on-one sessions with a tobacco-cessation specialist who provides support for quitting. 
Community-based tobacco-cessation programs include group classes, such as those offered 
by the American Cancer Society, American Lung Association, or other community-based 
organizations.
The impact of WISEWOMAN’s increased emphasis on reducing tobacco use among 
participants is seen by the trend in linkages to quitlines. In the first year of the 
WISEWOMAN program ( July 1, 2008, through June 30, 2009), 32% of screening visits by 
a current smoker were linked to a quitline (from a total of 8,327 screening visits with current 
smokers, 2,660 were linked at least once to a quitline). In the fifth year of the program ( July 
1, 2012, through June 30, 2013), 38% of screening visits by current smokers were linked to a 
quitline (from a total of 12,170 screening visits with current smokers, 4,620 were linked at 
least once to a quitline), a rate increase of 6%. Overall, the cumulative referrals to state 
quitlines from July 1, 2008, through June 30, 2013, were 27,408. Some smokers were linked 
more than once to a quitline; therefore, 20,100 unique visits by smokers were referred at 
least once to a quitline, representing approximately 36% of all WISEWOMAN screening 
visits by smokers (Table 3).
Notably, the use of tobacco-cessation counseling greatly increased in the last 2 years of the 
program after it placed additional emphasis on tobacco cessation. From July 1, 2008, to June 
30, 2011, fewer than 3% of all WISEWOMAN participants who smoked received a tobacco-
cessation counseling LSI. From July 1, 2011, to June 30, 2012, nearly 37% of smokers 
received a tobacco-cessation counseling LSI. In the final program year ( July 1, 2012, to 
June 30, 2013), 40% of smokers received a tobacco-cessation counseling LSI.
Since 2008, program procedures have included community-based tobacco-cessation 
program contacts for WISEWOMAN participants. Although there is significant variation in 
the availability of such programs, many women have benefited from them. From July 1, 
2008, to June 30, 2013, the 15,926 screening visits with current smokers were linked to at 
least one community-based tobacco-cessation program, or 29% of all smokers in the 
program (Table 3).
The sustained focus on tobacco cessation over the years has allowed the WISEWOMAN 
program to observe a 15% smoking-cessation rate among smokers at baseline screening who 
returned for a rescreening visit. The WISEWOMAN program defined cessation among its 
Vaid et al. Page 7













participants as those who self-identified as smokers at the baseline screening visit and as 
nonsmokers at the last rescreening visit. Rescreening visits typically occurred every 12 to 18 
months after the baseline screening.
Smoking-cessation rates varied by participants’ race and ethnicity. WISEWOMAN Hispanic 
participants had the highest cessation rate; approximately 34% of Hispanic women who 
were once smokers quit by their last rescreening visit. On the other hand, non-Hispanic 
white women had the lowest cessation rate, with only about 13% quitting by their last 
rescreening visit.
Odds ratios using logistic regression models were used to determine what attributes 
increased the likelihood that a woman who was a smoker at her baseline clinic screening 
visit would become a nonsmoker at her last rescreening visit. Race and ethnicity had a 
statistically significant effect on the odds of quitting smoking. Hispanic women had the 
greatest odds for becoming nonsmokers at their last rescreening visit (OR = 3.32, p < 
0.0001, 95% CI: 2.80–3.94) when compared to non-Hispanic white women. Other racial and 
ethnic minorities followed the same trend line when compared to non-Hispanic white 
women. Non-Hispanic American Indian/Alaskan Natives (OR = 1.53, p < 0.0001, 95% CI: 
1.27–1.85), non-Hispanic blacks (OR = 1.36, p = 0.0002, 95% CI: 1.16–1.60), and non-
Hispanic Asian/Pacific Islanders (OR = 3.69, p < 0.0001, 95% CI: 1.94–7.00) were more 
likely to become nonsmokers than were non-Hispanic white women. The CI for non-
Hispanic Asian/Pacific Islanders (4%) is wide, which can be explained by the variance in the 
small sample size of smokers in this group (Table 4).
Age was statistically significant in quitting smoking; older women had a slightly higher OR 
of becoming nonsmokers (OR = 1.01, p = 0.0033; 95% CI: 1.00–1.02). Furthermore, there 
was a statistically significant relationship between the number of rescreening visits and odds 
of smoking cessation. For every additional rescreening visit a woman attended, her odds of 
becoming a nonsmoker increased by 1.18 ( p = 0.0033, 95% CI: 1.06–1.31) (Table 4). This 
supports program guidance to maintain contact with women and to emphasize the 
importance of returning for a rescreening.
Discussion
This program update is reflective of a practice program rather than a research program; 
therefore, we are limited to reporting changes in the population who chose to continue in the 
program and return for rescreenings. These participants were enrolled in any of the 21 state 
and tribal WISEWOMAN programs. Therefore, our analyses are limited to the enrolled 
population. Some of the data collected were self-reported values and were reliant on the 
accuracy of those responses. This is especially true for smoking status. In addition, data 
validation was done at the program level, which may have resulted in missing and/or 
excluded data for which the cause is unknown. Further, as this was a 5-year program, some 
women may have aged out of or lost eligibility for the program. These situations limited the 
opportunities to capture rescreening-visit data. Finally, WISEWOMAN participants who 
quit smoking may have been more highly motivated than other WISEWOMAN participants; 
thus, the cessation rate may be lower than reported.
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In addition to affecting health behavior in individuals, the WISEWOMAN program is an 
example of the synergy achieved when individual care, clinical processes, and community 
environmental changes occur. As a result, long-term changes occur in clinical policies and 
procedures, professional development for healthcare providers, and community norms that 
affect the larger population served by these healthcare providers.
Final reports from programs indicate successes at many different levels in reducing tobacco 
use across all 21 programs and over the 5-year funding, with the overall data showing 
increased quitline referrals and decreased smoking rates among WISEWOMAN 
participants. The program, based on 5 years of data, has exhibited a 15% smoking-cessation 
rate among women who were smokers at their baseline visit and quit at their last rescreening 
visit. The unique combination of direct individual health services and population-based 
strategies has contributed to this reduction in smoking prevalence and has had a positive 
impact on women’s cardiovascular health over the past 5-year cooperative agreement.
The WISEWOMAN program began a new 4-year funding cycle on July 1, 2013; 
WISEWOMAN programs will implement a number of program strategies to build on the 
achievements from prior years. These strategies include gathering information to monitor 
and evaluate the tobacco use of participants and their exposure to secondhand smoke and 
developing or enhancing partnerships with state tobacco-control programs to reduce tobacco 
use and eliminate exposure to secondhand smoke. WISEWOMAN program guidance will 
continue to address cessation counseling and referral to appropriate cessation resources. In 
addition, programs will work closely with partners in their state tobacco-control program 
and at the state quitline to monitor participants’ use of quitline services. Programs will 
continue to refer smokers to the most appropriate cessation services available. Strong 
emphasis will continue on working closely with healthcare providers to ensure that all clinic 
patients are referred to smoking-cessation services. WISEWOMAN will continue its 
successful efforts to reduce smoking rates among program participants and to contribute to 
the reduction of CVD risk in uninsured and underserved women.
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Racial and ethnic profile of WISEWOMAN participants: June 1, 2008, through July 30, 
2013.
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Education profile of WISEWOMAN participants: June 1, 2008, through July 30, 2013.
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Age distribution of WISEWOMAN participants: June 1, 2008, through July 30, 2013 <1%.
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Table 1
Participation of Fax to Quit Training by Profession in the Pennsylvania WISEWOMAN Program (N = 680)
Professions Percentage
Physicians 3









Other clinical staff 18
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Table 2
Cardiovascular Disease Risk-Factor Profile Among WISEWOMAN Participants: July 1, 2008, to June 30, 
2013
Risk factors Women screened (n = 149,767)
Hypertensiona
 Normal blood pressure 31% (45,789)
 Prehypertension 29% (43,819)
 Hypertension 40% (59,075)
Cholesterolb
 Normal 42% (59,208)
 Borderline high 27% (37,751)
 High 31% (43,958)
Diabetesc
 Normal glucose 67% (91,741)
 Prediabetes 16% (21,941)
 Diabetes 17% (23,825)
Smokingd
 Smoker 28% (40,500)
 Nonsmoker 72% (106,953)
Secondhand smokee
 No exposure 82% (36,910)
 One or more days 16% (7,749)
Body mass indexf
 Normal 24% (34,415)
 Overweight 29% (42,046)
 Obese 48% (69,276)
Missing and excluded values were not included in this table.
a
Hypertension: normal blood pressure, average SBP < 120mm Hg and average DBP < 80 mmHg; prehypertension, average SBP 120–139mmHg or 
average DBP 80–89 mmHg; hypertension, average SBP ≥ 140mmHg or average DBP ≥ 90mmHg or taking medication for high blood pressure.
b
Cholesterol: normal total cholesterol (fasting/nonfasting), < 200mg/dL; borderline high cholesterol, total cholesterol (fasting/nonfasting) 200–
239mg/dL; high cholesterol, total cholesterol (fasting/nonfasting) ≥ 240mg/dL or taking medication for high cholesterol.
c
Diabetes: normal glucose, fasting glucose < 100 mg/dL, nonfasting glucose < 140 mg/dL, or A1c < 5.7%; prediabetes, fasting glucose 100–125 
mg/dL or nonfasting glucose 140–199 mg/dL or A1c ≥ 5.7%; diabetes, fasting glucose > 125 mg/dL, nonfasting glucose > 199 mg/dL, A1c ≥ 6.5%, 
history of diabetes, or taking medication for diabetes.
d
Smoking: participant reports smoking every day or some days.
e
Secondhand smoke: one or more days of exposure to secondhand tobacco smoke inside the participant’s home within the past 7 days (not 
including exposure on decks, porches, or garages).
f
Body mass index: normal, < 24; overweight, 25–30; obese, ≥ 30.
Alc, glycated hemoglobin; DBP, diastolic blood pressure; SBP, systolic blood pressure.
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Table 3
Types of Tobacco-Cessation Services Provided to WISEWOMAN Participants June 1, 2008, to July 30, 2013
Type of tobacco resource Frequency
Quitline
 Total number of linkages to tobacco quitline 27,408
 Total number of screening visits by all current smokers 55,726
 Total number of screening visits by current smokers with at least one linkage to quitline 20,100
 Percentage of screening visits by current smokers with at least one linkage to quitline 36%
Cessation counseling through LSI
 Total number of cessation counseling LSI sessions 13,403
 Total number of screening visits by all current smokers 24,082a
 Total number of screening visits by current smokers with at least one LSI session 9,259
 Percentage of screening visits by a current smoker with at least one LSI session 38%
Community-based cessation programs
 Total number of community-based tobacco-cessation program contacts 23,875
 Total number of screening visits by all current smokers 55,726
 Total number of screening visits by current smokers with at least one community-based cessation-program contact 15,926
 Percentage of screening visits by current smoker with at least one community-based cessation-program contact 29%
a
The n for tobacco cessation as part of an LSI is lower, as this service was not fully implemented until the fourth program year, which started on 
July 1, 2011.
LSI, lifestyle intervention.
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Table 4
Attributes Affecting the Odds a Woman Would Quit Smoking by Her Last Rescreening Visit (June 1, 2008, to 
July 30, 2013)
Variablesa Adjusted OR 95% CI p value
Age at baseline 1.01 1.00–1.02 0.0033
Hispanic 3.32 2.80–3.94 < 0.0001
Non-Hispanic American Indian/Alaskan Native 1.53 1.27–1.85 < 0.0001
Non-Hispanic Asian/Pacific Islander 3.69 1.94–7.00 < 0.0001
Non-Hispanic black 1.36 1.16–1.60 0.0002
Number of rescreening visits 1.18 1.06–1.31 0.0033
a
Reference for race/ethnicity: non-Hispanic white; reference for number of rescreening visits: OR increases per extra visit; reference for age at 
baseline: a 1-year age increase from one woman compared to another similar woman.
CI, confidence interval; OR, odds ratio.
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